Individualized Assessment of Motor Function & Balance in Intensive Therapy

Status Active, not recruiting

Clinical Trial Summary

The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Children 7-17 years old who can walk and are completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests will be selected including common balance tests (standing with eyes open, standing with eyes closed), walking, walking and turning, standing up and sitting down from a bench, reaction time, and step down. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care.

Clinical Trial Description

The goal of this study is to assess the individualized use of instrumented assessment of motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the intervention. Children 7-17 with neurodevelopmental diagnosis, GMFCS Levels I and II and completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests in single and dual conditions will be selected including Romberg balance tests, walking, walking and turning, sit to/from stand, reaction time, and step down administered while participant is recorded using a portable measurement platform which incorporates a custom force plate, Azure Kinect spatial sensor, and interface board. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care. Testing is estimated to last for 45 minutes. ;

Study Design

Related Conditions & MeSH terms

Neurodevelopmental Disorders

Clinical Trial Details

NCT number	NCT05820412
Study type	Observational
Source	University of Missouri-Columbia
Contact
Status	Active, not recruiting
Phase
Start date	May 22, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03148782` - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase	N/A
Active, not recruiting	`NCT04935593` - Strengthening Social, Emotional and Behavioral Resilience	N/A
Recruiting	`NCT03222375` - SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism	N/A
Completed	`NCT04313283` - Translating Peer-to-Peer Support Into a Clinical Setting	N/A
Completed	`NCT04562935` - Long-term Consequences of Admission for Pediatric Intensive Care Before One Year of Age
Not yet recruiting	`NCT05815095` - Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services
Recruiting	`NCT05017363` - Evaluation of the Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)	N/A
Completed	`NCT06251830` - Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
Completed	`NCT06052878` - Neurodevelopmental Outcome After Prenatal Anesthesia
Recruiting	`NCT06012903` - Lower Urinary Tract Symptoms and School Functioning in Children
Not yet recruiting	`NCT05490173` - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants	N/A
Not yet recruiting	`NCT06081348` - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders	Phase 2
Not yet recruiting	`NCT05564871` - Effectiveness of Occupational Therapy Teleintervention in Pediatric	N/A
Enrolling by invitation	`NCT02871674` - Good Night Project: Behavioural Sleep Interventions for Children With ADHD: A Randomised Controlled Trial	N/A
Completed	`NCT01922791` - Nutrition and Pregnancy Intervention Study	N/A
Active, not recruiting	`NCT05428657` - EC Brain Program for Children With Special Education Needs	N/A
Recruiting	`NCT06111898` - Neuro-biomechanical Determinants for Motor Behavior in High-risk Infants
Recruiting	`NCT05658965` - KIDSHEART AND BRAIN : Early EEG Surgery Congenital Heart Disease Predict Onset of Neurodevelopmental Disorders
Recruiting	`NCT06057441` - Auditory and Visual Noise as Possible Non-pharmacological Treatment of ADHD in School Children	N/A
Recruiting	`NCT06086951` - Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Individualized Assessment of Motor Function and Balance in Intensive Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms